tradmap

SNOA Earnings Sonoma Pharmaceuticals, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$11 -$5 $1 $0 2013 2014 2015 2022 2023 2024 2025 2026
EPS
Revenue (annual)
$0 $10M $20M 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Revenue
Net income (annual)
-$14M -$3M $9M $0 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Net income

Quarterly results

Diluted EPS (quarterly)
-$11 -$6 $0 Q3 '22 Q2 '23 Q4 '23 Q3 '24 Q2 '25 Q4 '25
EPS
Revenue (quarterly)
$0 $3M $6M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$1M -$742000 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–33 of 33
Q1 20272026-06-30-0.092026-08-0610-Q
FY 20262026-03-31-1.892026-06-1610-K
Q3 20262025-12-31-1.562026-02-1010-Q
Q2 20262025-09-30-1.082025-11-0410-Q
Q1 20272025-06-30-0.762026-08-0610-Q
FY 20262025-03-31-2.792026-06-1610-K
Q3 20262024-12-31-2.402026-02-1010-Q
Q2 20262024-09-30-1.862025-11-0410-Q
Q1 20262024-06-30-1.342025-08-0710-Q
FY 20252024-03-31-10.632025-06-1710-K
Q3 20252023-12-31-10.742025-02-0510-Q
Q2 20252023-09-30-11.472024-11-0710-Q
Q1 20252023-06-30-0.292024-08-0810-Q
FY 20242023-03-31-1.522024-06-1710-K
Q3 20242022-12-31-1.242024-02-0810-Q
Q2 20242022-09-30-0.612023-11-1310-Q
Q1 20242022-06-30-0.292023-08-1010-Q
FY 20232022-03-31-1.922023-06-2110-K
Q3 20232021-12-31-0.852023-02-1410-Q
Q2 20232021-09-30-0.542022-11-1410-Q
Q1 20232021-06-30-0.522022-08-1110-Q
Q3 20222020-12-31-0.152022-02-1110-Q
Q2 20222020-09-300.172021-11-1510-Q
Q1 20222020-06-300.132021-08-1610-Q
Q2 20212019-09-30-0.372020-11-2010-Q
Q1 20212019-06-300.542020-08-1410-Q
Q1 20202018-06-30-4.992019-08-1310-Q
Q3 20182017-12-31-2.212018-02-1410-Q
Q3 20182016-12-312.792018-02-1410-Q
Q3 20172015-12-31-2.272017-02-1710-Q
FY 20152015-03-31-0.852015-06-1610-K
FY 20152014-03-310.542015-06-1610-K
FY 20142013-03-31-1.302014-06-3010-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.